<p>泰尼特保健（NYSE:THC - 獲取免費報告）在週四發佈給客户和投資者的研究報告中，華爾街分析師將其目標價格從 238.00 美元上調至 252.00 美元，Benzinga 報道。該公司目前對該股票給予 “增持” 評級。華爾街分析師的目標價格暗示該股票當前價格有 27.81% 的潛在上漲空間。</p>
<ul>
<li>當前值得關注的頂級分析師評級醫療股票</li>
</ul>
<p>其他股票分析師最近也對該股票發佈了報告。瑞穗證券將泰尼特保健的目標價格從 194.00 美元上調至 225.00 美元，並在 10 月 17 日的研究報告中給予該公司 “跑贏大盤” 評級。巴克萊將泰尼特保健的目標價格從 208.00 美元上調至 229.00 美元，並在 9 月 18 日的報告中給予該公司 “增持” 評級。Truist Financial 在 11 月 3 日的報告中重申了 “買入” 評級，並將泰尼特保健的目標價格設定為 240.00 美元（上調自 225.00 美元）。摩根士丹利在 10 月 29 日的研究報告中將泰尼特保健的目標價格設定為 232.00 美元，並給予該股票 “增持” 評級。最後，KeyCorp 在 10 月 8 日的報告中將泰尼特保健的目標價格從 205.00 美元上調至 225.00 美元，並給予該股票 “增持” 評級。一位股票研究分析師給予該股票 “強烈買入” 評級，十六位分析師給予 “買入” 評級，四位分析師給予 “持有” 評級。根據 MarketBeat 的數據，該股票目前的共識評級為 “適度買入”，平均目標價格為 227.13 美元。</p>
<p>獲取 <strong>泰尼特保健</strong> 的提醒：</p>
<p><strong>查看我們關於泰尼特保健的最新研究報告</strong></p>
<h2>泰尼特保健價格表現</h2>
<ul>
<li>3 家低調的醫療公司</li>
</ul>
<p>週四，THC 股價下跌 2.83 美元，報 197.16 美元。該股票交易量為 154,244 股，而其平均交易量為 1,415,734 股。該公司的債務與股本比率為 2.27，流動比率為 1.71，速動比率為 1.63。泰尼特保健的 12 個月低點為 109.82 美元，12 個月高點為 217.43 美元。該公司的市值為 173.3 億美元，市盈率為 13.51，PEG 比率為 0.89，貝塔值為 1.53。該公司的 50 日移動平均線為 198.89 美元，200 日移動平均線為 177.72 美元。</p>
<p>泰尼特保健（NYSE:THC - 獲取免費報告）最近在 10 月 28 日發佈了其財報。該公司報告季度每股收益為 3.70 美元，超出分析師一致預期的 3.33 美元，超出幅度為 0.37 美元。泰尼特保健的淨利潤率為 6.49%，股本回報率為 25.11%。該公司季度收入為 52.9 億美元，而分析師預期為 52.6 億美元。去年同期，該公司的每股收益為 2.93 美元。該公司的季度收入同比增長 3.2%。泰尼特保健已將其 2025 財年的指導目標設定為 15.930-16.26 每股收益。賣方分析師預測，泰尼特保健在當前財年將發佈 12.24 每股收益。</p>
<h2>內部人士下注</h2>
<ul>
<li>HCA Healthcare：短期挫折，長期實力</li>
</ul>
<p>在其他泰尼特保健的新聞中，董事理查德·W·費舍爾在 10 月 29 日的交易中出售了 2,500 股該公司的股票。股票以平均價格 208.43 美元出售，總價值為 521,075.00 美元。交易完成後，該董事持有 8,792 股公司股票，價值 1,832,516.56 美元。該交易使其持股減少了 22.14%。該交易已在證券交易委員會的備案中披露，相關信息可在此鏈接查看。此外，首席執行官 Saumya Sutaria 在 9 月 10 日的交易中出售了 78,762 股該公司的股票。股票以平均價格 190.78 美元出售，總價值為 15,026,214.36 美元。交易完成後，首席執行官直接持有 368,683 股公司股票，價值約 70,337,342.74 美元。這代表其持股減少了 17.60%。該銷售的披露信息可在 SEC 備案中查看。在過去三個月中，內部人士共出售了 134,044 股公司股票，價值 25,977,997 美元。公司內部人士持有公司股票的 0.81%。</p>
<h2>泰尼特保健的機構交易</h2>
<p>幾家對沖基金和其他機構投資者最近也買賣了該股票的股份。AlphaQuest LLC 在第二季度將其在泰尼特保健的股份增加了 230.8%。AlphaQuest LLC 現在擁有 1,763 股公司股票，價值 310,000 美元，此前在該期間內又購買了 1,230 股。加拿大皇家銀行在第一季度將其在泰尼特保健的持倉增加了 34.0%。加拿大皇家銀行現在擁有 119,349 股公司股票，價值 16,052,000 美元，此前在該期間內又購買了 30,281 股。Leith Wheeler Investment Counsel Ltd.在第二季度將其在泰尼特保健的持倉增加了 22.2%。Leith Wheeler Investment Counsel Ltd.現在擁有 82,813 股公司股票，價值 14,575,000 美元，此前在該期間內又購買了 15,019 股。Cullen Frost Bankers Inc.在第二季度將其在泰尼特保健的持倉增加了 46.6%。Cullen Frost Bankers Inc.現在擁有 601 股公司股票，價值 106,000 美元，此前在該期間內又購買了 191 股。最後，瑞銀資產管理美洲有限公司的一個獨立業務單位在第一季度將其在泰尼特保健的股份增加了 4.9%。瑞銀資產管理美洲有限公司的一個獨立業務單位現在擁有 276,969 股公司股票，價值 37,252,000 美元，此前在上個季度又購買了 12,914 股。機構投資者持有公司股票的 95.44%。</p>
<h2>關於泰尼特保健</h2>
<p>（獲取免費報告）</p>
<p>泰尼特保健公司在美國作為一家多元化的醫療服務公司運營。該公司通過兩個部門運營：醫院運營與服務，以及門診護理。其綜合醫院提供急性護理服務、手術和恢復室、放射學和呼吸治療服務、臨牀實驗室和藥房。</p>
<h2>進一步閲讀</h2>
<ul>
<li>五隻我們認為比泰尼特保健更好的股票</li>
<li>什麼是低市盈率，它對投資者意味着什麼？</li>
<li>AMD 到 300 美元看起來很容易——這裏是為什麼 500 美元可能是下一個</li>
<li>什麼是 MarketRank™？如何使用它</li>
<li>超過 50 億美元的回購：DraftKings、AppLovin 和 Altria 在告訴你什麼</li>
<li>黃金交叉股票：模式、示例和圖表</li>
<li>4 只高收益房地產股票，投資者開始防禦性投資時購買</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRIQw"/></p>
<p><em>此即時新聞提醒由敍述科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在泰尼特保健嗎？</h2>
<p>在考慮泰尼特保健之前，你會想聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而泰尼特保健並不在名單上。</p>
<p>雖然泰尼特保健目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

泰尼特保健

<p>富國銀行將泰尼特保健的目標價格從 238.00 美元上調至 252.00 美元，維持 “增持” 評級，暗示潛在上漲幅度為 27.81%。其他分析師也提高了他們的目標價格，普遍給予 “適度買入” 評級，平均目標價格為 227.13 美元。泰尼特保健最近的財報超出預期，內部人士則在出售股票。該股交易價格為 197.16 美元，市值為 173.3 億美元</p>

<p>Tenet Healthcare (NYSE:THC - Get Free Report) had its price objective boosted by equities research analysts at Wells Fargo &amp; Company from $238.00 to $252.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has an &#34;overweight&#34; rating on the stock. Wells Fargo &amp; Company's price target would suggest a potential upside of 27.81% from the stock's current price.</p>
<div class="lb-trans"><p>泰尼特保健（NYSE:THC - 獲取免費報告）在週四發佈給客户和投資者的研究報告中，華爾街分析師將其目標價格從 238.00 美元上調至 252.00 美元，Benzinga 報道。該公司目前對該股票給予 “增持” 評級。華爾街分析師的目標價格暗示該股票當前價格有 27.81% 的潛在上漲空間。</p>
</div><ul>
<li>Top Analyst-Rated Healthcare Stocks to Watch Now</li>
</ul>
<div class="lb-trans"><ul>
<li>當前值得關注的頂級分析師評級醫療股票</li>
</ul>
</div><p>Other equities analysts have also recently issued reports about the stock. Mizuho upped their price target on shares of Tenet Healthcare from $194.00 to $225.00 and gave the company an &#34;outperform&#34; rating in a research report on Friday, October 17th. Barclays boosted their price objective on Tenet Healthcare from $208.00 to $229.00 and gave the company an &#34;overweight&#34; rating in a report on Thursday, September 18th. Truist Financial reaffirmed a &#34;buy&#34; rating and set a $240.00 price objective (up from $225.00) on shares of Tenet Healthcare in a report on Monday, November 3rd. Morgan Stanley set a $232.00 target price on Tenet Healthcare and gave the stock an &#34;overweight&#34; rating in a research note on Wednesday, October 29th. Finally, KeyCorp lifted their price objective on Tenet Healthcare from $205.00 to $225.00 and gave the stock an &#34;overweight&#34; rating in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $227.13.</p>
<div class="lb-trans"><p>其他股票分析師最近也對該股票發佈了報告。瑞穗證券將泰尼特保健的目標價格從 194.00 美元上調至 225.00 美元，並在 10 月 17 日的研究報告中給予該公司 “跑贏大盤” 評級。巴克萊將泰尼特保健的目標價格從 208.00 美元上調至 229.00 美元，並在 9 月 18 日的報告中給予該公司 “增持” 評級。Truist Financial 在 11 月 3 日的報告中重申了 “買入” 評級，並將泰尼特保健的目標價格設定為 240.00 美元（上調自 225.00 美元）。摩根士丹利在 10 月 29 日的研究報告中將泰尼特保健的目標價格設定為 232.00 美元，並給予該股票 “增持” 評級。最後，KeyCorp 在 10 月 8 日的報告中將泰尼特保健的目標價格從 205.00 美元上調至 225.00 美元，並給予該股票 “增持” 評級。一位股票研究分析師給予該股票 “強烈買入” 評級，十六位分析師給予 “買入” 評級，四位分析師給予 “持有” 評級。根據 MarketBeat 的數據，該股票目前的共識評級為 “適度買入”，平均目標價格為 227.13 美元。</p>
</div><p>Get <strong>Tenet Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>泰尼特保健</strong> 的提醒：</p>
</div><p><strong>Check Out Our Latest Research Report on Tenet Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我們關於泰尼特保健的最新研究報告</strong></p>
</div><h2>Tenet Healthcare Price Performance</h2>
<div class="lb-trans"><h2>泰尼特保健價格表現</h2>
</div><ul>
<li>3 Under-the-Radar Healthcare Companies</li>
</ul>
<div class="lb-trans"><ul>
<li>3 家低調的醫療公司</li>
</ul>
</div><p>THC traded down $2.83 on Thursday, hitting $197.16. 154,244 shares of the stock were exchanged, compared to its average volume of 1,415,734. The company has a debt-to-equity ratio of 2.27, a current ratio of 1.71 and a quick ratio of 1.63. Tenet Healthcare has a 12 month low of $109.82 and a 12 month high of $217.43. The firm has a market capitalization of $17.33 billion, a price-to-earnings ratio of 13.51, a PEG ratio of 0.89 and a beta of 1.53. The business has a 50-day moving average of $198.89 and a two-hundred day moving average of $177.72.</p>
<div class="lb-trans"><p>週四，THC 股價下跌 2.83 美元，報 197.16 美元。該股票交易量為 154,244 股，而其平均交易量為 1,415,734 股。該公司的債務與股本比率為 2.27，流動比率為 1.71，速動比率為 1.63。泰尼特保健的 12 個月低點為 109.82 美元，12 個月高點為 217.43 美元。該公司的市值為 173.3 億美元，市盈率為 13.51，PEG 比率為 0.89，貝塔值為 1.53。該公司的 50 日移動平均線為 198.89 美元，200 日移動平均線為 177.72 美元。</p>
</div><p>Tenet Healthcare (NYSE:THC - Get Free Report) last issued its earnings results on Tuesday, October 28th. The company reported $3.70 earnings per share for the quarter, beating analysts' consensus estimates of $3.33 by $0.37. Tenet Healthcare had a net margin of 6.49% and a return on equity of 25.11%. The firm had revenue of $5.29 billion for the quarter, compared to analyst estimates of $5.26 billion. During the same quarter last year, the business posted $2.93 earnings per share. The company's quarterly revenue was up 3.2% on a year-over-year basis. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. Sell-side analysts forecast that Tenet Healthcare will post 12.24 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>泰尼特保健（NYSE:THC - 獲取免費報告）最近在 10 月 28 日發佈了其財報。該公司報告季度每股收益為 3.70 美元，超出分析師一致預期的 3.33 美元，超出幅度為 0.37 美元。泰尼特保健的淨利潤率為 6.49%，股本回報率為 25.11%。該公司季度收入為 52.9 億美元，而分析師預期為 52.6 億美元。去年同期，該公司的每股收益為 2.93 美元。該公司的季度收入同比增長 3.2%。泰尼特保健已將其 2025 財年的指導目標設定為 15.930-16.26 每股收益。賣方分析師預測，泰尼特保健在當前財年將發佈 12.24 每股收益。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>內部人士下注</h2>
</div><ul>
<li>HCA Healthcare: Temporary Setbacks, Long-Term Strength</li>
</ul>
<div class="lb-trans"><ul>
<li>HCA Healthcare：短期挫折，長期實力</li>
</ul>
</div><p>In other Tenet Healthcare news, Director Richard W. Fisher sold 2,500 shares of the business's stock in a transaction that occurred on Wednesday, October 29th. The shares were sold at an average price of $208.43, for a total value of $521,075.00. Following the completion of the transaction, the director owned 8,792 shares of the company's stock, valued at $1,832,516.56. The trade was a 22.14% decrease in their position. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is available at this hyperlink. Also, CEO Saumya Sutaria sold 78,762 shares of the firm's stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $190.78, for a total value of $15,026,214.36. Following the transaction, the chief executive officer directly owned 368,683 shares in the company, valued at approximately $70,337,342.74. This represents a 17.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 134,044 shares of company stock valued at $25,977,997 over the last three months. Corporate insiders own 0.81% of the company's stock.</p>
<div class="lb-trans"><p>在其他泰尼特保健的新聞中，董事理查德·W·費舍爾在 10 月 29 日的交易中出售了 2,500 股該公司的股票。股票以平均價格 208.43 美元出售，總價值為 521,075.00 美元。交易完成後，該董事持有 8,792 股公司股票，價值 1,832,516.56 美元。該交易使其持股減少了 22.14%。該交易已在證券交易委員會的備案中披露，相關信息可在此鏈接查看。此外，首席執行官 Saumya Sutaria 在 9 月 10 日的交易中出售了 78,762 股該公司的股票。股票以平均價格 190.78 美元出售，總價值為 15,026,214.36 美元。交易完成後，首席執行官直接持有 368,683 股公司股票，價值約 70,337,342.74 美元。這代表其持股減少了 17.60%。該銷售的披露信息可在 SEC 備案中查看。在過去三個月中，內部人士共出售了 134,044 股公司股票，價值 25,977,997 美元。公司內部人士持有公司股票的 0.81%。</p>
</div><h2>Institutional Trading of Tenet Healthcare</h2>
<div class="lb-trans"><h2>泰尼特保健的機構交易</h2>
</div><p>Several hedge funds and other institutional investors have recently bought and sold shares of the stock. AlphaQuest LLC increased its stake in shares of Tenet Healthcare by 230.8% during the second quarter. AlphaQuest LLC now owns 1,763 shares of the company's stock valued at $310,000 after buying an additional 1,230 shares during the period. Royal Bank of Canada increased its position in Tenet Healthcare by 34.0% during the 1st quarter. Royal Bank of Canada now owns 119,349 shares of the company's stock valued at $16,052,000 after purchasing an additional 30,281 shares during the period. Leith Wheeler Investment Counsel Ltd. lifted its position in shares of Tenet Healthcare by 22.2% in the 2nd quarter. Leith Wheeler Investment Counsel Ltd. now owns 82,813 shares of the company's stock worth $14,575,000 after purchasing an additional 15,019 shares during the period. Cullen Frost Bankers Inc. increased its position in shares of Tenet Healthcare by 46.6% during the second quarter. Cullen Frost Bankers Inc. now owns 601 shares of the company's stock valued at $106,000 after buying an additional 191 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Tenet Healthcare by 4.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 276,969 shares of the company's stock worth $37,252,000 after buying an additional 12,914 shares in the last quarter. Institutional investors own 95.44% of the company's stock.</p>
<div class="lb-trans"><p>幾家對沖基金和其他機構投資者最近也買賣了該股票的股份。AlphaQuest LLC 在第二季度將其在泰尼特保健的股份增加了 230.8%。AlphaQuest LLC 現在擁有 1,763 股公司股票，價值 310,000 美元，此前在該期間內又購買了 1,230 股。加拿大皇家銀行在第一季度將其在泰尼特保健的持倉增加了 34.0%。加拿大皇家銀行現在擁有 119,349 股公司股票，價值 16,052,000 美元，此前在該期間內又購買了 30,281 股。Leith Wheeler Investment Counsel Ltd.在第二季度將其在泰尼特保健的持倉增加了 22.2%。Leith Wheeler Investment Counsel Ltd.現在擁有 82,813 股公司股票，價值 14,575,000 美元，此前在該期間內又購買了 15,019 股。Cullen Frost Bankers Inc.在第二季度將其在泰尼特保健的持倉增加了 46.6%。Cullen Frost Bankers Inc.現在擁有 601 股公司股票，價值 106,000 美元，此前在該期間內又購買了 191 股。最後，瑞銀資產管理美洲有限公司的一個獨立業務單位在第一季度將其在泰尼特保健的股份增加了 4.9%。瑞銀資產管理美洲有限公司的一個獨立業務單位現在擁有 276,969 股公司股票，價值 37,252,000 美元，此前在上個季度又購買了 12,914 股。機構投資者持有公司股票的 95.44%。</p>
</div><h2>About Tenet Healthcare</h2>
<div class="lb-trans"><h2>關於泰尼特保健</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.</p>
<div class="lb-trans"><p>泰尼特保健公司在美國作為一家多元化的醫療服務公司運營。該公司通過兩個部門運營：醫院運營與服務，以及門診護理。其綜合醫院提供急性護理服務、手術和恢復室、放射學和呼吸治療服務、臨牀實驗室和藥房。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Tenet Healthcare</li>
<li>What is a Low P/E Ratio and What Does it Tell Investors?</li>
<li>AMD to $300 Looks Easy—Here’s Why $500 Could Be Next</li>
<li>What is MarketRank™? How to Use it</li>
<li>$5B+ in Buybacks: What DraftKings, AppLovin, and Altria Are Telling You</li>
<li>Golden Cross Stocks: Pattern, Examples and Charts</li>
<li>4 High-Yield Real Estate Stocks to Buy as Investors Get Defensive</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比泰尼特保健更好的股票</li>
<li>什麼是低市盈率，它對投資者意味着什麼？</li>
<li>AMD 到 300 美元看起來很容易——這裏是為什麼 500 美元可能是下一個</li>
<li>什麼是 MarketRank™？如何使用它</li>
<li>超過 50 億美元的回購：DraftKings、AppLovin 和 Altria 在告訴你什麼</li>
<li>黃金交叉股票：模式、示例和圖表</li>
<li>4 只高收益房地產股票，投資者開始防禦性投資時購買</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRIQw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=THC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Tenet Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在泰尼特保健嗎？</h2>
</div><p>Before you consider Tenet Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮泰尼特保健之前，你會想聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而泰尼特保健並不在名單上。</p>
</div><p>While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然泰尼特保健目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

富國銀行的分析師表示，泰尼特保健（NYSE:THC）的股價預計將會上漲